BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30239174)

  • 1. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
    Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
    Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer.
    Cui Y; Huang Y; Wu X; Zheng M; Xia Y; Fu Z; Ge H; Wang S; Xie H
    J Cell Physiol; 2019 Jun; 234(6):8740-8751. PubMed ID: 30362543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tRNA-derived fragments (tRFs) as potential candidates for diagnosis of nontriple negative breast cancer.
    Huang Y; Ge H; Zheng M; Cui Y; Fu Z; Wu X; Xia Y; Chen L; Wang Z; Wang S; Xie H
    J Cell Physiol; 2020 Mar; 235(3):2809-2824. PubMed ID: 31535382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
    Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
    Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
    Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
    Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
    J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
    Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
    Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S; Yu H; Zhou D; Fan X; Duan Y; Tan Y; Lang M; Shao G
    J Transl Med; 2023 Oct; 21(1):721. PubMed ID: 37838657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.
    Telonis AG; Rigoutsos I
    Cancer Res; 2018 Mar; 78(5):1140-1154. PubMed ID: 29229607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel long non-coding RNAs in triple-negative breast cancer.
    Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
    Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J; Xue X; Jiang K
    Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.